Affordable Access

Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.

Type
Published Article
Journal
Lancet (London, England)
Publication Date
May 06, 2000
Volume
355
Issue
9215
Pages
1588–1596
Identifiers
PMID: 10821362
Source
Medline
License
Unknown

Abstract

The inclusion of levamisole in chemotherapy regimens for colorectal cancer does not delay recurrence or improve survival. Higher-dose folinic acid produced no extra benefit in these regimens over that from low-dose folinic acid. Trials of chemotherapy versus no chemotherapy will show whether these four treatments are equally effective or equally ineffective.

Report this publication

Statistics

Seen <100 times